Brazil Clinical Laboratory Tests Market Size & Outlook
Brazil clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
Brazil clinical laboratory tests market highlights
- The Brazil clinical laboratory tests market generated a revenue of USD 2,264.9 million in 2023 and is expected to reach USD 4,855.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, hba1c tests was the largest revenue generating type in 2023.
- Basic metabolic panel is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical laboratory tests market data book summary
| Market revenue in 2023 | USD 2,264.9 million |
| Market revenue in 2030 | USD 4,855.1 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Hba1c tests |
| Fastest growing segment | Basic metabolic panel |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.0% of the global clinical laboratory tests market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil clinical laboratory tests market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 4,855.1 million by 2030.
Hba1c tests was the largest segment with a revenue share of 11.37% in 2023. Horizon Databook has segmented the Brazil clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is one of the lucrative markets in the region. The increasing prevalence of chronic diseases, developing economy, and reforms in the country’s healthcare system are key factors driving the growth of the clinical laboratory tests market.
Moreover, Brazil has replaced its Committee of Ethics with an electronic submission system, which helps in accelerating the process of test assessment and clinical trials. This is expected to significantly boost market growth.
Currently, Brazil is highly impacted by the COVID-19 pandemic and the number of hospitalized patients is continuously increasing. Increasing number of hospitalized COVID-19 patients is expected to increase the demand for clinical laboratory tests. Moreover, the demand for clinical tests is expected to grow.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil clinical laboratory tests market size, by type, 2018-2030 (US$M)
Brazil Clinical Laboratory Tests Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
